Incretins, explained slowly: what GLP-1 and GIP actually do in your body

The word incretin sounds technical, but the idea behind it is one your body performs quietly after every meal. Incretins are hormones your gut releases when you eat. Their job is to tell the rest of the body that food has arrived and that it is time to manage the incoming energy. The two that matter most in current medicine are called GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). Understanding them is the single most useful thing you can do before forming an opinion about the medicines built around them.

Hormones are messages, not commands

It helps to picture hormones as short messages the body sends to itself. After a meal, cells lining your intestine release GLP-1 and GIP into the bloodstream. Those messages reach the pancreas, the brain, the stomach and other organs, and each reads the message slightly differently. Nothing is forced; the body is simply better informed about what to do next.

GLP-1 carries several messages at once. It nudges the pancreas to release insulin — but, importantly, only when blood sugar is actually high. It slows down how quickly the stomach empties, so a meal is released into the gut more gradually. And it speaks to the parts of the brain involved in appetite and fullness, which is why people who take GLP-1-based medicines often describe feeling satisfied sooner.

These hormones do not override the body. They amplify a conversation it is already having with itself.

GIP is the quieter partner in research terms, but it also acts on insulin release and on how the body handles fat. Some newer medicines are designed to work on both GLP-1 and GIP pathways at once. The details of that combination are still being studied, and this is exactly the kind of area where honest sources say "we are still learning" rather than promising certainty.

Why "glucose-dependent" is the crucial phrase

One feature of incretin biology explains a lot of what people notice. GLP-1 encourages insulin release in proportion to how high blood sugar is. When blood sugar is normal, the signal quietens down. This glucose-dependent behaviour is a large part of why these mechanisms behave the way they do compared to older approaches — though how any individual responds still depends on their own health, and that is a conversation for them and their doctor, not a website.

A tool, not a shortcut

It is tempting, when a mechanism is this elegant, to imagine it as effortless. That framing does a disservice to the people who actually use these therapies. Appetite, weight, blood sugar and metabolic health are shaped by sleep, stress, movement, food, genetics and circumstance. A medicine that acts on one part of that system is a genuine tool — and like any tool, it works best in trained hands, with follow-up, and as part of a bigger picture. That is why prescription and regular medical review are not bureaucratic hurdles but the core of using these therapies responsibly.

Our aim at the society is not to persuade you toward or away from anything. It is to make sure that when you sit down with a healthcare professional, you already understand the vocabulary — so the conversation can be about you, and not about undoing something you read online.